BDSX
Biodesix, Inc.
Price:  
6.83 
USD
Volume:  
38,458.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biodesix, EV/EBITDA

-527.2%
Upside

As of 2025-10-22, the EV/EBITDA ratio of Biodesix, Inc. (BDSX) is -1.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Biodesix,'s latest enterprise value is 50.06 mil USD. Biodesix,'s TTM EBITDA according to its financial statements is -27.68 mil USD. Dividing these 2 quantities gives us the above Biodesix, EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 6.0x - 9.0x 7.8x
Forward P/E multiples 5.5x - 9.0x 7.6x
Fair Price (22.51) - (33.84) (29.17)
Upside -429.6% - -595.4% -527.2%
6.83 USD
Stock Price
(29.17) USD
Fair Price

Biodesix, EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA